J9229 Injection inotuzumab ozogam 0.1 milligrams
J-Codes
Also known as: inotuzumab ozogamicin, Besponsa
Intravenous injection of inotuzumab ozogamicin, a monoclonal antibody-drug conjugate targeting CD22, dosed per 0.1 milligram.
Clinical Context
Used for relapsed or refractory B-cell acute lymphoblastic leukemia.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.